#Q3

The usefulness of ophthalmoscopy in risk evaluation of hypertensive patients

Coll-de-Tuero G, Foguet Q, Vargas S, Saez M, Barceló MA. Blood Pressure 2002; 11:1-8. doi: 10.1080/080370502320779467 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)

Clinical epidemiology Eye fundus FRCV GLM model Method:Generalized models Q3 Selection on observables:Regression models
Relación a corto plazo de la contaminación atmosférica y la mortalidad en trece ciudades españolas

Ballester F, Íñiguez C, Saez M, Pérez-Hoyos S, Daponte A, Ordóñez JM, Barceló MA, Taracido M, Arribas F, Bellido J, Cambra K, Cañada A, Guillén JJ. Medicina Clínica 2003; 121(18):684-689 (Impact Factor: 1.277, MEDICINE, GENERAL & INTERNAL 91/160 Q3)

Environmental epidemiology GAM model GLM model Method:Generalized models Mortality Q3 Selection on observables:Regression models
Usefulness of optic fundus examination with retinography in initial evaluation of hypertensive patients

Foguet Q, Rodríguez A, Saez M, Ubieto A, Beltrán M, Barceló MA, Coll-de-Tuero G. American Journal of Hypertension 2008; 21(4):400-405. doi: 10.1038/ajh.2008.3 (Impact Factor: 2.530, PERIPHERAL VASCULAR DISEASE 33/65 Q3)

Download
Clinical epidemiology Eye fundus FRCV GLM model Method:Generalized models Q3 Selection on observables:Regression models
Why is cardiovascular risk stratification important in hypertensive patients?

Coll-de-Tuero G, Saez M, Rodríguez-Poncelas A, Barceló MA, Vargas-Vila S, Garré-Olmo J, Sala V, Sieira A, Gelada E, Gelado-Ferrero J. Blood Pressure 2012; 21(3):182-190. doi: 10.3109/08037051.2012.681109 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)

Clinical epidemiology FRCV GLM model Method:Generalized models Q3 Selection on observables:Regression models White coat
Prognostic value of the estimated glomerular filtration rate decline in hypertensive patients without chronic kidney disease

Coll-de-Tuero G, Comas-Cufí M, Rodríguez-Poncelas A, Barrot J, Blanch J, Figa A, Barceló MA , Saez M. American Journal of Hypertension 2019; 32(9):890-899. doi: 10.1093/ajh/hpz029 (Impact Factor: 2.530, PERIPHERAL VASCULAR DISEASE 33/65 Q3)

Clinical epidemiology FRCV GLM model Kidney disease and glomerular filtration Method:Generalized models Q3 Selection on observables:Regression models
Read more